Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2022-03-14 00:00:00 ET · period of report 2022-03-10 · accession 0001567619-22-006946 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-14 | 2022-03-10+ | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | M - OptEx | $37.46 | +30.0K | 353.6K | +9% | +$1.12M |
| DM | 2022-03-14 | 2022-03-10+ | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | S - Sale+OE | $77.69 | -30.0K | 338.6K | -8% | -$2.33M |
| DM | 2022-03-14 | 2022-03-10+ | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | M - OptEx | $0.00 | -30.0K | 85.0K | -26% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-10 | M | A | 15,000 | $37.46 | 353,569 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on December 9, 2021. |
| 2 | Common | Common Stock | 2022-03-11 | S | D | 15,000 | $77.81 | 338,569 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on December 9, 2021. |
| 3 | Common | Common Stock | 2022-03-11 | M | A | 15,000 | $37.46 | 353,569 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on December 9, 2021. |
| 4 | Common | Common Stock | 2022-03-10 | S | D | 15,000 | $77.57 | 338,569 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on December 9, 2021. |
| 5 | Derivative | Stock Option (Right to buy Common Stock) | 2022-03-10 | M | D | 15,000 | $0.00 | 100,000 | D | $37.46 · 2012-11-08 to 2022-05-07 | 15,000 Common Stock | (F1) Trade made pursuant to a 10b5-1 plan executed on December 9, 2021. (F2) Reflects the number of options outstanding after the transactions from this specific stock option grant. |
| 6 | Derivative | Stock Option (Right to buy Common Stock) | 2022-03-11 | M | D | 15,000 | $0.00 | 85,000 | D | $37.46 · 2012-11-08 to 2022-05-07 | 15,000 Common Stock | (F1) Trade made pursuant to a 10b5-1 plan executed on December 9, 2021. (F2) Reflects the number of options outstanding after the transactions from this specific stock option grant. |